189 related articles for article (PubMed ID: 34077908)
1. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic delays are common among patients with hepatocellular carcinoma.
Patel N; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2015 May; 13(5):543-9. PubMed ID: 25964640
[TBL] [Abstract][Full Text] [Related]
3. Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Clin Gastroenterol Hepatol; 2023 May; 21(5):1281-1292.e10. PubMed ID: 35933076
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
6. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis.
Rich NE; Phen S; Desai N; Mittal S; Yopp AC; Yang JD; Marrero JA; Iyengar P; Infante RE; Singal AG
Clin Gastroenterol Hepatol; 2022 May; 20(5):e1157-e1169. PubMed ID: 34555519
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M
PLoS One; 2021; 16(8):e0256544. PubMed ID: 34437610
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.
Singal AG; Waljee AK; Patel N; Chen EY; Tiro JA; Marrero JA; Yopp AC
J Natl Compr Canc Netw; 2013 Sep; 11(9):1101-8. PubMed ID: 24029125
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis.
Choi DT; Davila JA; Sansgiry S; David E; Singh H; El-Serag HB; Sada YH
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1679-1687. PubMed ID: 32693047
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a Voice Messaging System is Associated With Improved Time-to-Treatment and Overall Survival in Patients With Hepatocellular Carcinoma.
Mokdad A; Browning T; Mansour JC; Zhu H; Singal AG; Yopp AC
J Natl Compr Canc Netw; 2016 Jan; 14(1):38-46. PubMed ID: 26733553
[TBL] [Abstract][Full Text] [Related]
12. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
[TBL] [Abstract][Full Text] [Related]
13. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
Yang JD; Luu M; Singal AG; Noureddin M; Kuo A; Ayoub WS; Sundaram V; Kotler H; Kim IK; Todo T; Voidonikolas G; Brennan TV; Kosari K; Klein AS; Hendifar A; Lu SC; Nissen NN; Gong J
J Natl Compr Canc Netw; 2020 Sep; 18(9):1210-1220. PubMed ID: 32886898
[TBL] [Abstract][Full Text] [Related]
15. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
16. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
Mehta N; Parikh ND; Kelley RK; Hameed B; Singal AG
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1520-1530. PubMed ID: 32652308
[TBL] [Abstract][Full Text] [Related]
17. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
Pinato DJ; Allara E; Chen TY; Trevisani F; Minguez B; Zoli M; Harris M; Dalla Pria A; Merchante N; Platt H; Jain M; Caturelli E; Kikuchi L; Pineda J; Nelson M; Farinati F; Rapaccini GL; Aytaman A; Yin M; Tan CK; Bower M; Giannini EG; Bräu N;
J Clin Oncol; 2019 Feb; 37(4):296-304. PubMed ID: 30562130
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study.
Rasic G; Beaulieu-Jones BR; Chung SH; Romatoski KS; Kenzik K; Ng SC; Tseng JF; Sachs TE
Ann Surg Oncol; 2023 Jul; 30(7):4249-4259. PubMed ID: 37099088
[TBL] [Abstract][Full Text] [Related]
19. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey.
Zhao H; Zhou A; Zhou J; Bi X; Yan S; Jin J; Wei W; Li M; Gong C; Chen Q; Luo Z; Li N; Mao R; Chen X; Chen B; Zheng R; Zhao J; Han Y; Li Z; Che X; Tang Y; Sun Y; Huang Z; Zhang Y; Wang X; Zhang Y; Lu Z; Dang X; Song T; Liu C; Yue P; Yan D; Yue A; Zhang R; Luo S; Tan J; Zhang X; Bai X; Zhang X; He M; Xie Y; Wang W; Yang P; Yang Y; Zhang Y; Li Q; Peng T; Wang Z; Chen Y; Shang C; Liang Y; Zhang B; Zhang F; Wang L; Li D; Liu B; Zhu X; Hu Q; Chen M; Xiu D; Xia F; Zhang Y; Zeng Y; Mao Y; Li X; Ba Y; Liang T; Shen F; Liu L; Cai X; Zhou J; Cai J
HPB (Oxford); 2022 Mar; 24(3):342-352. PubMed ID: 34400051
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
